AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Industrial Minerals Ltd

0.105

-0.005-4.55%

Volume:35.39K

Turnover:4K

Market Cap:17.08M

PE:-12.80

High:0.105

Open:0.105

Low:0.105

Close:0.110

52wk High:0.200

52wk Low:0.092

Shares:162.69M

Float Shares:117.64M

Volume Ratio:0.82

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.008

ROE:-19.12%

ROA:-9.97%

PB:4.09

PE(LYR):-12.80

Loading ...

Overview Company News Filings

Noxopharm Says US FDA Feedback Supports Planned Phase II Trial Approach for Autoimmune Drug Candidate

MT Newswires Live

Australia's Industrial Minerals Jumps After Securing Exploration Licence for Gold Project

Industrial Minerals Ltd-North Pool Tenement Granted

THOMSON REUTERS

Kringle Pharma Submits IND Application for Spinal Cord Injury Drug to U.S. FDA; Shares Jump 7%

MT Newswires Live

Industrial Minerals Ltd-Appendix 4G & Corporate Governance Statement

THOMSON REUTERS

Celltrion Secures IND Application Amendment Approvals for CT-P44, CT-P51 Phase 3 Trial

MT Newswires Live

Industrial Minerals Ltd-Change in Substantial Holding X2

THOMSON REUTERS

Industrial Minerals Ltd-S708a Cleansing Notice

THOMSON REUTERS

Industrial Minerals Ltd-Application for Quotation of Securities - Ind

THOMSON REUTERS

Industrial Minerals - Jeffrey Sweet Steps Down as Managing Director, Continues as Non-Executive Director

THOMSON REUTERS

Industrial Minerals Ltd-Completion of Galleon Metals Acquisition & Board Changes

THOMSON REUTERS

Industrial Minerals Ltd-Geophysics Confirms Strong Gold Target at Laverton

THOMSON REUTERS

Industrial Minerals Ltd-Results of Meeting

THOMSON REUTERS

Trump: University of Miami donates 1994 Ibogaine IND to accelerate treatment for veterans

Trump's Truth Social latest posts

Caliway Biopharma Submits China Phase 1 IND for CBL-514 Fat-Reduction Drug

MT Newswires Live

Celltrion Submits Dual-Part EMA Application for Subcutaneous Rheumatoid Arthritis Drug

MT Newswires Live

Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA

MT Newswires Live

BUZZ-Australia's Industrial Minerals jumps on onshore gold find

Industrial Minerals Ltd-High-Grade Historic Gold Results Confirmed at Laverton

THOMSON REUTERS

Antengene Secures China IND Approval for Autoimmune Disease Drug

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/IND.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IND.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IND.AU\",,,,,undefined,":{"symbol":"IND.AU","market":"AU","secType":"STK","nameCN":"Industrial Minerals Ltd","latestPrice":0.105,"timestamp":1791436260142,"preClose":0.11,"halted":0,"volume":35394,"delay":0,"changeRate":-0.0454545454545455,"nameEN":"Industrial Minerals Ltd","floatShares":117637614,"shares":162690117,"eps":-0.0082,"marketStatus":"Post Close","change":-0.005,"latestTime":"10-08 16:16:24 AEDT","open":0.105,"high":0.105,"low":0.105,"amount":3716,"amplitude":0,"askPrice":0.125,"askSize":71000,"bidPrice":0.105,"bidSize":197848,"shortable":3,"etf":0,"ttmEps":-0.0082,"tradingStatus":3,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":15,"adr":0,"exchange":"ASX","adjPreClose":0.11,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":0.822653,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IND.AU","preClose":0.11,"auctionPrice":0.105,"auctionVolume":122,"auction":3,"marketStatus":"盘后竞价","timestamp":1790230142616}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IND.AU\",,,,,undefined,":{"symbol":"IND.AU","floatShares":117637614,"roa":"-9.97%","roe":"-19.12%","lyrEps":-0.0082,"volumeRatio":0.822653,"shares":162690117,"dividePrice":0,"high":0.105,"amplitude":0,"preClose":0.11,"low":0.105,"week52Low":0.092,"pbRate":"4.09","psRate":"20409.15","week52High":0.2,"institutionHeld":0,"latestPrice":0.105,"committee":0.471821,"eps":-0.0082,"divideRate":0,"volume":35394,"delay":0,"ttmEps":-0.0082,"open":0.105,"prevYearClose":0.13,"prevWeekClose":0.105,"prevMonthClose":0.099,"prevQuarterClose":0.099,"fiveDayClose":0.105,"twentyDayClose":0.1,"sixtyDayClose":0.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673044724","title":"Noxopharm Says US FDA Feedback Supports Planned Phase II Trial Approach for Autoimmune Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044724","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044724?lang=en_us&edition=fundamental","pubTime":"2026-10-08 10:24","pubTimestamp":1791426258,"startTime":"0","endTime":"0","summary":"Noxopharm   said the US Food and Drug Administration has provided constructive feedback that was supportive of its planned approach for a phase II clinical trial for SOF-SKN, its autoimmune disease drug candidate, according to a Thursday Australian bourse filing.The company said the feedback provides increased regulatory clarity, and helps de-risk the drug candidate's development pathway, while it will incorporate the feedback into preparations for a future investigational new drug  submission that has the potential to increase SOF-SKN's commercial attractiveness.The phase II trial is targeted for the first half of calendar 2028, subject to regulatory, clinical and manufacturing requirements, it said.The company said an orphan drug designation opportunity exists for SOF-SKN, given there are no current targeted therapies.The company's shares fell nearly 2% in recent Thursday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IND.AU","IND","BK4585","LABU","BK7095","BK7067","BK7501","BK4588","NOX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672735573","title":"Australia's Industrial Minerals Jumps After Securing Exploration Licence for Gold Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2672735573","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672735573?lang=en_us&edition=fundamental","pubTime":"2026-10-01 09:02","pubTimestamp":1790816533,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Industrial Minerals jumps after securing exploration licence for gold project** Shares of Australia's Industrial MineralsIND.AXrise as much as 6.1% to A$0.105, their biggest intraday ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL6N45N020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7104","IND.AU","FML.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672780288","title":"Industrial Minerals Ltd-North Pool Tenement Granted","url":"https://stock-news.laohu8.com/highlight/detail?id=2672780288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672780288?lang=en_us&edition=fundamental","pubTime":"2026-10-01 06:15","pubTimestamp":1790806542,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUE7BSDGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669456062","title":"Kringle Pharma Submits IND Application for Spinal Cord Injury Drug to U.S. FDA; Shares Jump 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669456062","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669456062?lang=en_us&edition=fundamental","pubTime":"2026-09-24 12:21","pubTimestamp":1790223665,"startTime":"0","endTime":"0","summary":"Kringle Pharma  submitted an Investigational New Drug  application to the U.S. Food and Drug Administration  to initiate a phase three clinical trial in the U.S. for acute spinal cord injury drug oremepermin alfa.The proprietary recombinant human HGF therapeutic, Oremepermin alfa, completed phase one/two and phase three trials in Japan for acute spinal cord injury, the late-stage clinical biopharmaceutical company said in a Thursday filing with the Japan bourse.The company is carrying out an additional Phase 3 trial to support a future regulatory submission, while the drug has secured orphan drug designation for acute SCI in Japan, the U.S. and Europe, it said.Shares of Kringle Pharma added nearly 7% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","IND","BK4588","BK4585","LABU","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462799","title":"Industrial Minerals Ltd-Appendix 4G & Corporate Governance Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462799?lang=en_us&edition=fundamental","pubTime":"2026-09-16 06:16","pubTimestamp":1789510581,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUE29CQ7P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665966063","title":"Celltrion Secures IND Application Amendment Approvals for CT-P44, CT-P51 Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665966063","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665966063?lang=en_us&edition=fundamental","pubTime":"2026-09-07 11:31","pubTimestamp":1788751888,"startTime":"0","endTime":"0","summary":"Celltrion  received approval for amendments to the investigational new drug  applications for the phase three clinical trials of CT-P44, a biosimilar to Darzalex, in South Korea, and CT-P51, a biosimilar to Keytruda, in the U.S., according to two separate bourse filings on Monday.The phase three clinical trial of CT-P44 will compare the efficacy and safety of the drug's subcutaneous formulation with Darzalex Faspro, both in combination with lenalidomide and dexamethasone. The trial involves patients with relapsed or refractory multiple myeloma. Celltrion aims to demonstrate CT-P44's biosimilarity to the original drug through efficacy and safety outcomes, the filing said.The phase three clinical trial of CT-P51 will compare the efficacy and safety of the drug with Keytruda in patients with previously untreated metastatic non-squamous non-small cell lung cancer. Celltrion plans to compare CT-P51's efficacy and safety outcomes with those of Keytruda, it said.Shares of Celltrion fell nearl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","IND","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664602038","title":"Industrial Minerals Ltd-Change in Substantial Holding X2","url":"https://stock-news.laohu8.com/highlight/detail?id=2664602038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664602038?lang=en_us&edition=fundamental","pubTime":"2026-09-02 09:59","pubTimestamp":1788314397,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUE3SBLCK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IND.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778971","title":"Industrial Minerals Ltd-S708a Cleansing Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778971","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778971?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:43","pubTimestamp":1787809394,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUEBGNWLS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778681","title":"Industrial Minerals Ltd-Application for Quotation of Securities - Ind","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778681?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:36","pubTimestamp":1787808972,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE2ZHZ2Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778502","title":"Industrial Minerals - Jeffrey Sweet Steps Down as Managing Director, Continues as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778502?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:35","pubTimestamp":1787808933,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE2QJW1P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662509778","title":"Industrial Minerals Ltd-Completion of Galleon Metals Acquisition & Board Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509778","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662509778?lang=en_us&edition=fundamental","pubTime":"2026-08-27 13:35","pubTimestamp":1787808933,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE2QJW1P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IND.AU","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661163246","title":"Industrial Minerals Ltd-Geophysics Confirms Strong Gold Target at Laverton","url":"https://stock-news.laohu8.com/highlight/detail?id=2661163246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661163246?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:03","pubTimestamp":1787522599,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nTUEBCXRJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661592912","title":"Industrial Minerals Ltd-Results of Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2661592912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661592912?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:05","pubTimestamp":1787281548,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nTUE9Q1DRT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660949985","title":"Trump: University of Miami donates 1994 Ibogaine IND to accelerate treatment for veterans","url":"https://stock-news.laohu8.com/highlight/detail?id=2660949985","media":"Trump's Truth Social latest posts","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660949985?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:57","pubTimestamp":1787072260,"startTime":"0","endTime":"0","summary":"President Donald Trump announced on August 18 that the University of Miami has donated its original 1994 Ibogaine Investigational New Drug (IND) application to the federal government, a move he said...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://trumpstruth.org/statuses/40964","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","IND.AU","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656261587","title":"Caliway Biopharma Submits China Phase 1 IND for CBL-514 Fat-Reduction Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2656261587","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656261587?lang=en_us&edition=fundamental","pubTime":"2026-08-04 14:19","pubTimestamp":1785824364,"startTime":"0","endTime":"0","summary":"Caliway Biopharmaceuticals  submitted an investigational new drug  application to China's National Medical Products Administration's Center for Drug Evaluation for a phase one study of abdominal fact reduction drug.The CBL-0102 trial will evaluate the safety, tolerability and pharmacokinetic profile of CBL-514 in about 30 healthy Chinese subjects, following completion of a pre-IND meeting with the regulator.The company said the localized phase 1 study will assess potential racial differences in the drug's efficacy and safety between Chinese and non-Chinese populations, with a China phase 3 application planned after the phase 1 study is completed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IND","BK7095","IND.AU","CBL","BK4080","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653088115","title":"Celltrion Submits Dual-Part EMA Application for Subcutaneous Rheumatoid Arthritis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2653088115","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653088115?lang=en_us&edition=fundamental","pubTime":"2026-07-24 17:23","pubTimestamp":1784885030,"startTime":"0","endTime":"0","summary":"Celltrion  has submitted applications for its subcutaneous rheumatoid arthritis drug CT-P13 SC  to both the U.S. FDA  and the European Medicines Agency .The company seeks to demonstrate superiority over placebo at 12 weeks in a 296-patient, 52-week global Phase 3 trial, according to a bourse filing on Friday.The subcutaneous formulation, already approved for ulcerative colitis and Crohn's disease in multiple regions, aims to expand its indications and improve patient convenience through a broader treatment population.The company cautions that historically only about 10% of clinical trial drugs ultimately receive marketing approval, and results may fall short of expectations.While both filings share the same clinical design and commercial rationale, the EMA submission explicitly addresses the EU's revised Clinical Trials Regulation requiring separate Part 1  and Part 2  approvals.Both submissions support commercial differentiation through patient diversity, though investors are urged to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4081","BK7095","IND","EMA","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649118606","title":"Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2649118606","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649118606?lang=en_us&edition=fundamental","pubTime":"2026-07-07 12:17","pubTimestamp":1783397876,"startTime":"0","endTime":"0","summary":"Celltrion  submitted an investigational new drug  amendment for a global Phase 3 trial of CT-P51, the biosimilar of its cancer drug Keytruda, to the U.S. Food & Drug Administration, according to a Monday filing with the Korea Exchange.The randomized, double-blind, active-controlled clinical trial will enroll 220 previously untreated patients who have metastatic non-squamous non-small cell lung cancer to compare the efficacy and safety of CT-P51 against the reference drug over a two-year treatment period, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IND","BK7095","IND.AU","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645014973","title":"BUZZ-Australia's Industrial Minerals jumps on onshore gold find","url":"https://stock-news.laohu8.com/highlight/detail?id=2645014973","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645014973?lang=en_us&edition=fundamental","pubTime":"2026-06-22 08:47","pubTimestamp":1782089247,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Industrial Minerals jumps on onshore gold find** Shares of Industrial Minerals IND.AX rise as much as 12% to A$0.14, hitting their highest level since June 10** Stock marks strongest intraday trading session since May 28** Diversified miner confirms widespread gold mineralisation at onshore Laverton Gold Project** Stock up 7.7% YTD, including current session moves  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4N42U023:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7104","FML.AU","BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645601992","title":"Industrial Minerals Ltd-High-Grade Historic Gold Results Confirmed at Laverton","url":"https://stock-news.laohu8.com/highlight/detail?id=2645601992","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645601992?lang=en_us&edition=fundamental","pubTime":"2026-06-22 06:15","pubTimestamp":1782080138,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260621:nTUE20RCLT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642415735","title":"Antengene Secures China IND Approval for Autoimmune Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2642415735","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642415735?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:31","pubTimestamp":1781051482,"startTime":"0","endTime":"0","summary":"Antengene (HKG:6996) said China's National Medical Products Administration has approved an Investigational New Drug (IND) application for a Phase I study of ATG-201, according to a voluntary filing on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1574","IND.AU","BK7095","IND","BK1191","06996"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}